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A B S T R A C T
Background: Preeclampsia is the major cause of maternofetal and neonatal morbidity and mortality. Insulin-like growth factor (IGF) 
system has a crucial role in correct embryonic and placental development and growth. Conflicting data are available regarding IGF‑1 
in preeclamptic mothers. The extent to which leptin per se mediates the fetal growth and developmental abnormalities associated 
with preeclampsia remains to be clarified. Aim: Hence, the present study was planned to assess IGF-1 and leptin levels in maternal 
and cord blood of preeclamptics and to compare them with normotensive pregnant women. Subjects and Methods: The present 
study was conducted in the Department of Biochemistry in collaboration with the Department of Obstetrics and Gynaecology, 
Pt. B.D. Sharma, PGIMS, Rohtak. Totally, 25 normotensive pregnant and 25 preeclamptic women were enrolled, and serum leptin 
and IGF-1 levels were analyzed in maternal and cord blood of women by enzyme-linked immunosorbent assay. Results: IGF-I levels 
were lowered in maternal blood of preeclamptic as compared to normotensive mothers (P < 0.001). Leptin levels were significantly 
increased in preeclamptic mothers as compared to normotensive mothers (P < 0.001). Leptin had a positive correlation with IGF 
in both groups and it is highly statistically significant in preeclamptic mothers. Conclusion: Findings of the present study suggest 
that IGF-1 and leptin play a central role in controlling fetal growth.
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INTRODUCTION
The basic pathology of preeclampsia is intense vasospasm 
affecting whole of the vascular system, especially renal, 
uterine, and cerebral vessels, which is probably due to an 
increase in vasopressor substances such as angiotensin II, 
thromboxane A2, endothelin-1, and a decrease in vasodilator 
substances such as nitric oxide and prostacyclin due to 
endothelial cell dysfunction.[1]
The mechanisms regulating fetal growth are poorly 
understood. Apart from genetic predisposition, factors such 
as chromosomal aberrations, nutritional and environmental 
factors or toxic exposition during pregnancy, insulin, and 
insulin-like growth factors (IGFs) have been implicated as a 
primary determinant of fetal weight.
IGFs are released in response to growth hormone (GH) stimulation 
in the liver and act as hormones.[2] Furthermore, IGFs exerts 
mitogenic actions through paracrine and autocrine mechanisms 
to stimulate cellular proliferation and differentiation. 
IGF-binding proteins (IGFBPs) modulate the function of IGF-1. 
IGFBP-1 is synthesized by the fetal liver and is highly expressed 
in the decidua during pregnancy.[3] IGF-1 has been detected 
in preimplantation embryo and in syncytiotrophoblasts and 
cytotrophoblasts throughout gestation. During placentation, 
IGF producing “intermediate” trophoblast of the anchoring 
villus invades the IGFBP-1-rich maternal decidua to gain access 
to the maternal blood vessels.[4]
IGF-1 and IGFBP-1 modulate placental growth and reduced 
levels of IGF-1 and IGFBP-1 during late first trimester has 
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been reported.[4] The mechanism of effect of IGF-1 on fetal 
growth is not clear as maternal IGF-1 cannot cross the 
placenta. IGF-1 levels in umbilical cord blood have been 
reported to positively correlate with birth weight.[5]
Mouse leptin is secreted into circulation by adipocytes 
and crosses blood-brain barrier to binds its hypothalamic 
receptor causing downregulation of neuropeptide Y. 
Consecutively, a loss of food intake and an increase in 
energy expenditure lead to a reduction of body fat and body 
weight. Human obesity in children and adults has been 
associated with elevated serum leptin levels indicating its 
role in the regulation of body weight in humans.[6]
Leptin modulates satiety, energy homeostasis, and also 
reproductive biology ranging from paracrine effects in the 
placenta to regulation of conceptus development and fetal 
growth. High leptin concentrations have been reported in 
pregnant women than nonpregnant women,[7] and leptin 
increases significantly in women with preeclampsia that 
occurs due to increase in placental leptin production in 
preeclampsia in response to hypoxia.[8] Insulin may increase 
leptin levels, and after birth, there is a direct functional 
relation between leptin, GH, and IGF-1.[3,4] Although leptin 
levels have been correlated with insulin and IGF-1 level, 
observational study in humans indicates that its effects on 
fetal growth are independent of these axis and of adiposity.[9]
Conflicting data are available regarding IGF-1 in 
preeclamptic mothers. The possible association between 
fetal growth and levels of IGFs later in life needs to be 
explored. Furthermore, the extent to which leptin per se 
mediates the fetal growth and developmental abnormalities 
associated with preeclampsia remains to be clarified. Hence, 
the present study was planned to assess IGF-1 and leptin 
levels in maternal and cord blood of preeclamptics and to 
compare them with normotensive pregnant women.
SUBJECTS AND METHODS
The present study was conducted during 2011–2012 
in the Department of Biochemistry in collaboration 
with the Department of Obstetrics and Gynaecology, 
Pt. B. D. Sharma, PGIMS, Rohtak. This study was approved 
by the Ethics Review Committee of the institute. Fifty 
pregnant women attending the outpatient Department 
of Obstetrics and Gynaecology were randomly enrolled 
and divided into two groups: Group I (control, n = 25) 
normotensive women with singleton pregnancy at the 
time of delivery; and Group II (study, n = 25) age- and 
gestation-matched women with singleton pregnancy and 
systolic	 blood	 pressure	 ≥140	 mm	 Hg	 or	 diastolic	 blood	
pressure	≥90	mm	Hg	with	 or	without	 proteinuria	 at	 the	
time of delivery.
Informed consent was taken from all the patients. Women 
with a history of chronic hypertension, any metabolic 
disorder before or during pregnancy, or presence of 
high-risk factors such as heart disease, diabetes, renal 
disease were excluded.
Five milliliters of blood was drawn aseptically, and 
serum was separated by centrifugation. Ten milliliters of 
umbilical cord blood was drawn, and serum was separated. 
Routine investigations and serum leptin and IGF-1 levels 
were analyzed in maternal and cord blood of women 
with preeclampsia and normotensive pregnant women. 
DRG enzyme-linked immunosorbent assay (ELISA) kit 
for IGF-1 and leptin ELISA Kit for leptin estimation were 
based on solid phase ELISA (based on the sandwich 
principle).[10] Data were expressed in mean ± standard 
deviation; Student’s t-test and Pearson correlation were 
used. SPSS, version 17.0 was used in the analysis (SPSS Inc. 
Released 2008. SPSS Statistics for Windows, Version 17.0. 
Chicago: SPSS Inc.).
RESULTS
IGF-1 levels were lowered in maternal blood 
of preeclamptic as compared to normotensive 
mothers (P < 0.001) [Table 1]. Leptin levels were significantly 
increased in preeclamptic mothers as compared to 
normotensive mothers (P < 0.001) [Table 1 and Figure 1]. 
Cord blood IGF-1 levels were significantly decreased in 
Table 1: Maternal and cord blood insulin‑like growth factor‑1 
and leptin in both groups (mean±standard deviation)












Insulin-like growth factor-1 
(ng/ml)
259 (45.39) 72.2 (28.65) 73.2 (48.69) 33.2 (22.21)
Leptin (ng/ml) 21.77 (6.30) 10.02 (4.57) 57.48 (18.67) 24.27 (5.64)
Figure 1: Cord blood IGF-1 and leptin levels in both the groups
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high values of IGF-messenger (mRNA), with the greatest 
abundance at the invasive front, strongly suggesting the 
involvement of IGF in trophoblast invasive activity.[17] 
Reduced placental perfusion causes placental ischemia, 
angiogenic imbalance, and endothelial dysfunction leading 
to maternal hypertension. As a result of decreased IGF-1 
levels in preeclampsia, there is inadequate trophoblast 
invasion resulting in reduced placental perfusion. In vitro 
studies have shown that IGF-1 administration increases 
trophoblast invasion and glucose transport activity in 
first-trimester trophoblast cells lines, hence suggesting 
that IGF-1 may promote uterine spiral artery remodeling 
to provide adequate perfusion and nutrient supply to 
the uteroplacental unit.[18,19] Significantly lowered level 
of IGF-1 in preeclamptic mothers in the present study 
signifies the important role of this system in normal 
pregnancy.
Cord blood IGF-1 levels of preeclamptic mothers were 
significantly decreased as compared to cord blood of 
normotensive mothers.
Reduced placental perfusion pressure results in intrauterine 
growth restriction in offspring born of preeclamptic 
pregnancies.[20] Studies have reported that high maternal 
levels of IGF-1 regulate fetal weight and divert nutrients from 
mother to fetus, while maternal IGF-2 regulates placental 
development and maternal hemodynamic adaptation to 
pregnancy by increasing the maternal plasma volume.[21,22] 
Similarly, Bankowski et al. also showed that preeclampsia is 
associated with a decrease of IGF-1 content in the umbilical 
cord artery. Studies have reported that low IGF-1 levels are 
associated with endothelial dysfunction in hypertensive 
patients.[23]
The present study also showed that serum leptin levels 
of preeclampsia mothers were significantly increased as 
compared to normotensive mothers. It was also found that 
cord blood leptin levels in preeclamptics were also significantly 
increased as compared to normotensive mothers.
A considerable amount of leptin is secreted from the 
placental trophoblastic cells into the maternal circulation 
during pregnancy.[24] Metabolic changes such as glucose 
intolerance and insulin resistance encountered in obesity can 
also be seen in preeclampsia. Mise et al. showed an increase 
in placental leptin mRNA expression proportional to an 
increase in serum leptin levels in these patients.[8] Similarly, 
many studies have also detected a significant increase in 
plasma leptin levels in preeclamptic cases.[25-27]
The present study showed that cord blood IGF-1 and 
leptin levels were significantly lowered in both groups as 
compared to respective maternal levels.
preeclampsia mothers as compared to the normotensive 
mothers (P < 0.001) [Table 1], while serum leptin levels 
were significantly increased in preeclampsia mothers 
as compared to the normotensive mothers (P < 0.001) 
[Table 1 and Figure 1]. Maternal leptin and IGF-1 levels were 
about two-fold higher than fetal levels in both groups.
Maternal IGF-1 had a strong inverse correlation with leptin 
levels in preeclamptic mothers (r	=	−0.528, P < 0.01). No 
correlation was found between normotensive mother IGF-1 
and leptin levels. Cord blood IGF-1 had a negative correlation 
with cord blood leptin levels in both groups; however, it was 
statistically not significant in neither of these groups (r = 
−0.145,	r	=	−0.246, P = 0.49, P = 0.24.). IGF-1 has a negative 
correlation in normotensive mothers (r	=	−0.024),	while	
it has a positive correlation in preeclamptics (r = 0.407), 
although none of these correlations were significant. 
Leptin has a positive correlation with IGF in both groups 
and it is highly statistically significant in preeclamptic 
mothers (r = 0.231, r = 0.687; P = 0.27., P < 0.001 at both 
levels). Correlation between maternal and cord blood IGF-1, 
leptin is depicted in Table 2.
DISCUSSION
Conflicting evidence regarding alterations of IGFs in 
preeclamptic pregnancies are available in literature. 
Vatten et al. observed an increase in IGF-1 from the first to 
second trimester associated with preeclampsia, which the 
authors concluded was the result of placental disease.[11] 
Contradicting these findings, Ning et al. reported a decrease 
in free IGF-1 levels in early pregnancy associated with the risk 
of developing preeclampsia.[12] Ingec et al. observed lowered 
IGF-1 levels in late pregnancy in women who developed 
moderate and severe preeclampsia and eclampsia.[13] Cooley 
et al. and Hübinette et al. reported that IGF-1 levels are not 
changed in women with preeclampsia.[14,15] Wilson et al. 
reported the higher concentration of IGF-1 in the third 
trimester, probably reflecting placental contribution.[16]
The present study demonstrated significantly decreased 
serum IGF-1 levels in preeclampsia mothers as compared to 
the normotensive mothers.
IGF-1 is mainly expressed at the maternal-fetal interface in 
early human pregnancy. The trophoblast columns express 
Table 2: Correlation between maternal and cord blood 
insulin‑like growth factor‑1 and leptin levels in both groups
Maternal versus cord blood (ng/ml) Group I Group II
r P r P
Insulin-like growth factor-1 −0.024 0.910 0.231 0.27
Leptin 0.407 0.044 0.687 <0.001
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There was a strong significant inverse correlation of maternal 
IGF-1 had with leptin levels in preeclamptic mothers. Cord 
blood IGF-1 also had a negative nonsignificant correlation 
with cord blood leptin levels in both groups. No correlation 
was noted between normotensive mother IGF-1 and leptin 
levels. However, Hartman et al. reported that no correlation 
existed between IGF-1 and leptin.[28]
Renal dysfunction occurs in pregnant women with 
preeclampsia, and decreased renal clearance may be 
responsible for high leptin levels in preeclamptic women. 
Decreased plasma volume sometimes seen in preeclampsia 
may have a role in the increase in serum leptin level by 
causing hemoconcentration.
IGF-1 had a negative correlation in normotensive mothers 
while it had a positive correlation in preeclamptics although 
none of the correlation was significant. Leptin had a 
significant positive correlation in both groups. McCarthy 
et al. found a strong correlation between the maternal 
plasma leptin concentrations and umbilical cord blood 
leptin concentrations in preeclampsia.[25]
Taking into account the lack of a correlation between the 
maternal and umbilical cord blood leptin levels during normal 
pregnancy, it may be stated that the fetoplacental leptin 
regulation is a noncommunicating, double-compartment 
model. However, in preeclampsia, the strong correlation 
between the maternal and fetal leptin concentrations is 
indicative of a change resulting in communication between 
the two compartments.[25]
Placental hypoperfusion produces local hypoxia which 
consequently augments leptin gene expression in the 
placenta.[8] Inflammatory mediators such as tumor 
necrosis factor-α and interlukin-6 increase plasma leptin 
concentration.[29] Since leptin activates the sympathetic 
nervous system and stimulates catecholamine secretion, it 
is plausible that elevated leptin levels in maternal circulation 
may aggravate hypertension.[30]
Thus, there are several possible explanations for higher 
leptin concentrations in pregnancies complicated by 
preeclampsia. The exact mechanism underlying the increase 
in circulating leptin concentration in preeclampsia awaits 
further clarification.
The present study showed a significant inverse correlation 
of maternal IGF-1 with leptin levels in preeclamptics and 
no correlation was noted between normotensive mother 
IGF-1 and leptin levels. Cord blood IGF-1 had a negative 
nonsignificant correlation with cord blood leptin levels 
in both groups Similarly, Lepercq et al. and Christou et al. 
did not find any correlation between IGF-1 and leptin in 
normotensive pregnancies.[31,32]
IGF-1 had a positive correlation with birth weight in both 
normotensive and hypertensive groups; however, it is 
statistically significant only in cord blood of normotensive 
mothers. Reduced placental perfusion pressure results 
in intrauterine growth restriction in offspring born 
of preeclamptic pregnancies.[20] Clinical studies have 
reported a deficit in circulating and cord blood IGF-1 
levels in intrauterine growth-restricted newborns and a 
correlation between IGF-1 levels and birth weight.[33,34] 
Studies report that high maternal levels of IGF-1 regulate 
fetal weight and divert nutrients from mother to fetus. 
Wang et al. showed that the mean serum IGF-1 levels in the 
small-for-gestational-age group were significantly higher 
than those in average-for-gestational-age neonates.[35] Since 
IGF-1 cannot cross the placenta, circulating IGF-I may only 
be a secondary reflection of local tissue events involved in 
fetal growth.
Leptin showed a positive correlation with birth weight 
in normotensive mothers but a negative correlation in 
hypertensive mothers in the present study. There are many 
reports of positive correlation of birth weight and leptin 
among normotensive pregnancies in the literature.[32] The 
basis of this correlation may be due to direct relationship 
between adipose tissue mass and circulating leptin 
concentrations, and also from the placental source of 
leptin production.[24,36] Moreover, cord leptin levels are 
decreased by conditions that lead to low birth weight, such 
as maternal smoking and prematurity.[37] Whether leptin is 
directly implicated in determining fetal growth, or it simply 
represents a marker for fetal nutrition and growth, remains 
to be shown by future interventional studies. Serum leptin 
level has been reported to decrease following expelling of 
placenta after delivery[8] indicating that leptin increase in 
preeclamptics is related to placental production. Increase in 
placental leptin production reflects placental hypoperfusion 
and/or hypoxia, and hypoxia increases placental leptin 
production by inducing expression of placental genes in 
trophoblastic cells.[37-39]
There is increasing evidence that the foundations of 
life-long health are, in part, laid in the uterus. It seems likely 
that IGF-1 and leptin play a central role in controlling fetal 
growth.[37-39]
CONCLUSION
Findings of the present study suggest that IGF-1 and leptin 
play a central role in controlling fetal growth.
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